RAPT Therapeutics Q3 EPS $(12.41) Up From $(15.9) YoY

RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(12.41) per share. This is a 21.95 percent increase over losses of $(15.9) per share from the same period last year.

Benzinga · 12/11/2019 13:07

RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(12.41) per share. This is a 21.95 percent increase over losses of $(15.9) per share from the same period last year.